Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NuPOWER: Nuwiq for Perioperative Management in Severe Haemophilia A on Emicizumab
NCT05935358Phase 4Recruiting
- Sponsor
- Octapharma
- Start
- Nov 2023
- Primary completion
- Aug 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 11
01
Overview
A Phase 4 trial of simoctocog alfa in hemophilia A, sponsored by Octapharma. Started Nov 2023; status: recruiting.
02
Drugs
simoctocog alfa
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT05935358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05935358.